Sabra Healthcare REIT Inc. (SBRA) PT Raised to $20 at Scotiabank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts SBRA Hot Sheet
Price: $19.56 -0.2%
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Scotiabank analyst Nicholas Yulico raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $20.00 (from $19.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Freedom Broker Upgrades Goldman Sachs (GS) to Buy
- Tango Therapeutics Inc. (TNGX) PT Raised to $45 at Wedbush
- Pinnacle Financial Partners (PNFP) PT Raised to $115 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
